Literature DB >> 17626143

MMR: where are we now?

David Elliman1, Helen Bedford.   

Abstract

Mesh:

Substances:

Year:  2007        PMID: 17626143      PMCID: PMC2066086          DOI: 10.1136/adc.2006.103531

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  34 in total

1.  New evidence for a viral pathogenic mechanism for new variant inflammatory bowel disease and development disorder?

Authors:  A Morris; D Aldulaimi
Journal:  Mol Pathol       Date:  2002-04

2.  Comparison of social distribution of immunisation with measles, mumps, and rubella vaccine, England, 1991-2001.

Authors:  Elizabeth Middleton; Deborah Baker
Journal:  BMJ       Date:  2003-04-19

3.  Second dose of MMR vaccine: health professionals' level of confidence in the vaccine and attitudes towards the second dose.

Authors:  A Smith; R McCann; I McKinlay
Journal:  Commun Dis Public Health       Date:  2001-12

4.  Second dose of measles, mumps, and rubella vaccine: questionnaire survey of health professionals.

Authors:  M Petrovic; R Roberts; M Ramsay
Journal:  BMJ       Date:  2001-01-13

5.  A population-based study of measles, mumps, and rubella vaccination and autism.

Authors:  Kreesten Meldgaard Madsen; Anders Hviid; Mogens Vestergaard; Diana Schendel; Jan Wohlfahrt; Poul Thorsen; Jørn Olsen; Mads Melbye
Journal:  N Engl J Med       Date:  2002-11-07       Impact factor: 91.245

6.  Potential viral pathogenic mechanism for new variant inflammatory bowel disease.

Authors:  V Uhlmann; C M Martin; O Sheils; L Pilkington; I Silva; A Killalea; S B Murch; J Walker-Smith; M Thomson; A J Wakefield; J J O'Leary
Journal:  Mol Pathol       Date:  2002-04

7.  Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: population study.

Authors:  Brent Taylor; Elizabeth Miller; Raghu Lingam; Nick Andrews; Andrea Simmons; Julia Stowe
Journal:  BMJ       Date:  2002-02-16

8.  Detection and sequencing of measles virus from peripheral mononuclear cells from patients with inflammatory bowel disease and autism.

Authors:  H Kawashima; T Mori; Y Kashiwagi; K Takekuma; A Hoshika; A Wakefield
Journal:  Dig Dis Sci       Date:  2000-04       Impact factor: 3.199

9.  Rubella susceptibility among pregnant women in North London, 1996-1999.

Authors:  Pat A Tookey; Mario Cortina-Borja; Catherine S Peckham
Journal:  J Public Health Med       Date:  2002-09

10.  Evidence of persistent measles virus infection in Crohn's disease.

Authors:  A J Wakefield; R M Pittilo; R Sim; S L Cosby; J R Stephenson; A P Dhillon; R E Pounder
Journal:  J Med Virol       Date:  1993-04       Impact factor: 2.327

View more
  11 in total

1.  Improving uptake of MMR vaccine.

Authors:  Peter McIntyre; Julie Leask
Journal:  BMJ       Date:  2008-02-28

2.  Measles mimicking HIV seroconversion syndrome: a case report.

Authors:  Mahua T Chatterjee; Margaret Coleman; Gary Brook; Daniel McCrea
Journal:  J Med Case Rep       Date:  2010-02-06

Review 3.  The globalization of risk and risk perception: why we need a new model of risk communication for vaccines.

Authors:  Heidi Larson; Pauline Brocard Paterson; Ngozi Erondu
Journal:  Drug Saf       Date:  2012-11-01       Impact factor: 5.606

4.  A Bayesian space-time model for clustering areal units based on their disease trends.

Authors:  Gary Napier; Duncan Lee; Chris Robertson; Andrew Lawson
Journal:  Biostatistics       Date:  2019-10-01       Impact factor: 5.899

5.  Measles, mumps and rubella (MMR) vaccination has no effect on cognitive development in children - the results of the Polish prospective cohort study.

Authors:  Dorota Mrozek-Budzyn; Agnieszka Kiełtyka; Renata Majewska; Małgorzata Augustyniak
Journal:  Vaccine       Date:  2013-04-12       Impact factor: 3.641

6.  Attitudinal and demographic predictors of measles-mumps-rubella vaccine (MMR) uptake during the UK catch-up campaign 2008-09: cross-sectional survey.

Authors:  Katrina Brown; Graham Fraser; Mary Ramsay; Ruth Shanley; Noel Cowley; Johan van Wijgerden; Penelope Toff; Michelle Falconer; Michael Hudson; John Green; J Simon Kroll; Charles Vincent; Nick Sevdalis
Journal:  PLoS One       Date:  2011-05-13       Impact factor: 3.240

7.  Vaccine Hesitancy: A Growing Concern.

Authors:  Jonathan Kennedy
Journal:  Paediatr Drugs       Date:  2020-04       Impact factor: 3.930

Review 8.  Anti-cancer vaccines - a one-hit wonder?

Authors:  Justin K H Liu
Journal:  Yale J Biol Med       Date:  2014-12-12

9.  Current awareness: pharmacoepidemiology and drug safety.

Authors: 
Journal:  Pharmacoepidemiol Drug Saf       Date:  2008-06       Impact factor: 2.890

10.  A translational framework for public health research.

Authors:  David Ogilvie; Peter Craig; Simon Griffin; Sally Macintyre; Nicholas J Wareham
Journal:  BMC Public Health       Date:  2009-04-28       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.